Clinical Trials Sponsored by Hangzhou Cancer Hospital

Total 11250 results

Second Affiliated Hospital of Guangzhou Medical...

Recruiting

Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAIC

Hepatocellular Carcinoma | Thrombocytopenia

China
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

Lenvatinib, Sintilimab Plus SIRT for Unresectable HCC

Hepatocellular Carcinoma

China
Second Affiliated Hospital of Guangzhou Medical...

Not yet recruiting

Aribulin Combined With Carboplatin and Bevacizumab in the Treatment of Ovarian Cancer

Ovarian Cancer
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

Candonilimab (AK104) Plus Preoperative Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (ESCC)

Esophageal Squamous Cell Carcinoma

China
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

Effect of Heart Rate Control With Ivabradine on Hemodynamic in Patients With Sepsis

Sepsis | Hemodynamics | Heart Rate Control | Ivabradine

China
The First Affiliated Hospital of Zhengzhou University

Recruiting

Camrelizumab in Combination With Apatinib Mesylate Plus Short-course Chemotherapy for Advanced ESCC

Esophageal Cancer by AJCC V8 Stage

China
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

Lenvatinib Plus I-125 Seed Brachytherapy vs. Lenvatinib for TACE-refractory HCC

Hepatocellular Carcinoma Non-resectable

China
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

Lenvatinib+Sintilimab+TACE vs. Lenvatinib+TACE for Advanced HCC

Hepatocellular Carcinoma Non-resectable

China
Second Affiliated Hospital of Guangzhou Medical...

Not yet recruiting

An Exploratory Clinical Study of Photodynamic Therapy Combined With Sonodynamic Therapy in Cholangiocarcinoma

Cholangiocarcinoma
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

Esophageal Arterial Infusion Chemotherapy Versus Systemic Intravenous Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Prospective, Multicentre, Randomised Controlled Clinical Study

Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University

Recruiting

Angiogenesis Inhibitor Plus Anti-PD-1/PD-L1 Antibody in Advanced Esophageal Cancer (AIPAAIAEC)

Esophageal Neoplasms

China
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

Decitabine Plus Penpulimab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade

Esophageal Squamous Cell Carcinoma
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors

Sarcoma | Cervical Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Esophageal Cancer | Lung Cancer | Pancreas Cancer | Liver Cancer | Ovary Cancer

China
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

Comparison of the Efficacy and Safety of Immunoadsorption and Intravenous Immunoglobulin for Guillain-Barre Syndrome (GBS-PRAISING)

Guillain-Barre Syndrome

China
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

Study of CXCR5 Modified EGFR Targeted CAR-T Cells for Advanced NSCLC

Non Small Cell Lung Cancer

China
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

Chidamide Plus Camrelizumab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade

Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

Exploring the Safety and Effectiveness of Toripalimab Combined With Neoadjuvant Radiotherapy and Chemotherapy in the Locally Advanced Esophageal Squamous Cell Carcinoma

Locally Advanced Esophageal Squamous Cell Carcinoma

China
The First Affiliated Hospital of Zhengzhou University

Recruiting

Study of Perioperative Chemotherapy Combined With Tislelizumab and Trastuzumab in the Treatment of GC/EGC

Stomach Cancer

China
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

Trametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid Tumors

Hepatocellular Carcinoma | Solid Tumor, Adult

China
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs

Hepatocellular Carcinoma | Solid Tumor, Adult

China
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

Study of First-line Camrelizumab With or Without Chemotherapy for Advanced Esophageal Squamous Cell Cancer

Esophageal Cancer

China
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

A Phase Ⅱ Trials of Sintilimab as Consolidation Therapy After Radical Concurrent Chemoradiotherapy in Locally Advanced Unresectable ESCC

Esophageal Squamous Cell Carcinoma

China
The First Affiliated Hospital of Zhengzhou University

Recruiting

Survival Significance of Molecular Pathology and Genetic Variation in Brain Gliomas

Glioma | Molecular Sequence Variation | Genetic Change

China
The First Affiliated Hospital of Zhengzhou University

Recruiting

Azoospermia Patients

Healthy Related

China
The First Affiliated Hospital of Zhengzhou University

Recruiting

PCOS (Polycystic Ovarian Syndrome) Patients

Health Related

China
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

IT or IA Infusion of PD1/PDL1/CTLA4 Inhibitors Versus IV for Immunotherapy of Head/Neck Cancers (HNC)

Head/Neck Neoplasm

China
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

Study of Anti-PD-1 Antibody SHR-1210 Plus Nimotuzumab in the Treatment of Advanced Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

China
The First Affiliated Hospital of Zhengzhou University

Recruiting

Study of Anti-PD-1/PD-L1 Antibody Plus Apatinib as Second-Line Treatment of Advanced Esophageal Squamous Cell

Esophageal Cancer

China
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

CRRT Timing in Sepsis-associated AKI in ICU (CRTSAKI)

RTT | Sepsis-Associated Organ Dysfunction

China
Zeng Changhao

Completed

Acupuncture Therapy on Dysphagia in Parkinson's Disease

Parkinson Disease

Taiwan
Zeng Changhao

Terminated

Intermittent Oral-esophageal Tube in Delayed Dysphagia After Radiotherapy for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Zeng Changhao

Terminated

The Effect of Intermittent Oro-esophageal Tube Feeding on Severe Traumatic Brain Injury Patients With Tracheostomy

Traumatic Brain Injury

China
Zeng Changhao

Withdrawn

Effect of Intermittent Oro-esophageal Tube Feeding on Severe Traumatic Brain Injury Patient (IOE-TBI)

Traumatic Brain Injury

China
The First Affiliated Hospital of Zhengzhou University

Completed

Genetic Research on High Myopic Individuals in Northern China

High Myopia

China
Second Affiliated Hospital of Guangzhou Medical...

Completed

Preadmission Metformin Exposure and Incidence of Acute Kidney Injury

AKI

China
The First Affiliated Hospital of Zhengzhou University

Unknown

Botulinum Toxin for Trigeminal Neuralgia (EASTERN)

Trigeminal Neuralgia

China
Second Affiliated Hospital of Guangzhou Medical...

Unknown

Islet Allotransplantation for Type 1 Diabetic Patients

Type 1 Diabetic

China
The First Affiliated Hospital of Zhengzhou University

Unknown

Effect of Shorten Gonadotropin-releasing Hormone Agonist Therapy on the Outcome of in Vitro Fertilization-Embryo Transfer in Patients With Endometriosis

Clinical Pregnancy Rate

China
The First Affiliated Hospital of Zhengzhou University

Completed

Aminophylline for Patients With Post-Dural Puncture Headache

Post-dural Puncture Headache

China
Wuhan General Hospital of Guangzhou Military Command

Completed

Alpha-lipoic Acid Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery Disease

Coronary Artery Disease | Type 2 Diabetes | Left Ventricular Mass

China
Wei Yu

Completed

Safety Study of Autologous Bone Marrow Stromal Cells With Modification by Hepatocyte Growth Factor to Treat Silicosis

Silicosis
Shandong Cancer Hospital and Institute
Cancer Institute and Hospital, Chinese Academy of Medical Sciences; RenJi Hospital and other collaborators

Completed

Erbitux Combined With Chemo-radiotherapy in Esophageal Squamous Cell Carcinoma (EXCEL)

Esophageal Cancer

China
Dharmais National Cancer Center Hospital

Recruiting

The Effectiveness of Lymphatic Bypass Supermicrosurgery (ELYBS)

Breast Cancer Related Lymphedema | Lymphedema Arm

Indonesia
Cancer Institute and Hospital, Chinese Academy...
The First Affiliated Hospital with Nanjing Medical University; Fujian Cancer... and other collaborators

Recruiting

PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal Cancer

Esophageal Neoplasms

China
The Hong Kong Polytechnic University
Guangzhou First People's Hospital; Kowloon Hospital, Hong Kong; Tuen Mun Hospital and other collaborators

Completed

"Remind-to-move" for Promoting Upper Extremity Recovery in Patients With Stroke After Subacute Discharge

Stroke | Upper Extremity Hemiplegia
Second Affiliated Hospital, School of Medicine,...
Hangzhou Normal University

Completed

An Exploratory Study of Continuous Theta Burst Stimulation (cTBS) Based on fMRI in the Treatment of Tic Disorder

Tourette Syndrome | Tic Disorders

China
Zhengzhou University
Henan Provincial People's Hospital; Henan provincial interventional therapy...

Completed

Recanalization and Stenting for Non-acute Veterbrobasilar Artery Occlusion

Stroke

China
Cangzhou Hospital of Integrated Traditional Chinese...

Completed

US-Guided Superficial Cervical Plexus Block

Nerve Block

China
Cangzhou Hospital of Integrated Traditional Chinese...

Completed

USG Block of Cutaneous Nerves of the Arm

Nerve Block

China
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

Sintilimab Plus Bevacizumab and SIRT for Intermediate-advanced HCC

Hepatocellular Carcinoma Non-resectable

China

Clinical Trials Sponsored by Hangzhou Cancer Hospital

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations